Study of EV for Recurrent Endometrial Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Endometrial Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States
Contact: Study coordinator (Sukanya Skandarajah) · sskandarajah@mcw.edu · 4148055337
Contact: Study coordinator (Subana Paul) · supaul@mcw.edu · 4148058594
Contact: Principal Investigator (William H Bradley, MD)

Study leads

William Bradley, MD
Principal Investigator
Medical College of Wiscnson

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Neoplasms

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Palo Alto, United States

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Tucson, United States

Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies

Gynecologic Neoplasm · Brachytherapy · Therapeutic Touch

Abroad (travel likely)RecruitingPHASE2

Salt Lake City, United States

Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.

Non-Small Cell Lung Cancer · Sarcoma · Head &Amp; Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Angers, France · Marseille, France